These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10210720)

  • 1. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.
    Chen Y; McCall TW; Baichwal AR; Meyer MC
    J Control Release; 1999 May; 59(1):33-41. PubMed ID: 10210720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets.
    Chen Y; Jiao T; McCall TW; Baichwal AR; Meyer MC
    Pharm Dev Technol; 2002; 7(3):373-9. PubMed ID: 12229268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of an artificial neural network in the design of sustained-release dosage forms].
    Wei XH; Wu JJ; Liang WQ
    Yao Xue Xue Bao; 2001 Sep; 36(9):690-4. PubMed ID: 12580110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L
    J Control Release; 2002 Aug; 82(2-3):213-222. PubMed ID: 12175738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model.
    Mandal U; Gowda V; Ghosh A; Bose A; Bhaumik U; Chatterjee B; Pal TK
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):150-5. PubMed ID: 18239298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Petrović SD; Solomun L; Stupar B
    AAPS PharmSciTech; 2003; 4(1):E9. PubMed ID: 12916918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network.
    Xie H; Gan Y; Ma S; Gan L; Chen Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):363-72. PubMed ID: 18401778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of Salbutamol Sulfate Dissolution from Sustained Release Matrix Formulations Using an Artificial Neural Network.
    Chaibva F; Burton M; Walker RB
    Pharmaceutics; 2010 May; 2(2):182-198. PubMed ID: 27721350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G.
    Ivić B; Ibrić S; Cvetković N; Petrović A; Trajković S; Djurić Z
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):947-9. PubMed ID: 20606343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.
    Dowell JA; Hussain A; Devane J; Young D
    J Pharm Sci; 1999 Jan; 88(1):154-60. PubMed ID: 9874718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design porosity osmotic tablet for delivering low and pH-dependent soluble drug using an artificial neural network.
    Patel A; Mehta T; Patel M; Patel K; Patel N
    Curr Drug Deliv; 2012 Sep; 9(5):459-67. PubMed ID: 22746271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation.
    Barmpalexis P; Kanaze FI; Kachrimanis K; Georgarakis E
    Eur J Pharm Biopharm; 2010 Feb; 74(2):316-23. PubMed ID: 19815063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Melatonin Dissolution from Extended Release Matrices Using Artificial Neural Networking.
    Martarelli D; Casettari L; Shalaby KS; Soliman ME; Cespi M; Bonacucina G; Fagioli L; Perinelli DR; Lam JK; Palmieri GF
    Curr Drug Deliv; 2016; 13(4):565-73. PubMed ID: 26051184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.
    Leane MM; Cumming I; Corrigan OI
    AAPS PharmSciTech; 2003; 4(2):E26. PubMed ID: 12916908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks.
    Aktas E; Eroglu H; Kockan U; Oner L
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1207-16. PubMed ID: 22804226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of artificial neural networks in the design of controlled release drug delivery systems.
    Sun Y; Peng Y; Chen Y; Shukla AJ
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1201-15. PubMed ID: 12954199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formula optimization of theophylline controlled-release tablet based on artificial neural networks.
    Takayama K; Morva A; Fujikawa M; Hattori Y; Obata Y; Nagai T
    J Control Release; 2000 Aug; 68(2):175-86. PubMed ID: 10925126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.